Showing results (231-240 of 294) with videos related to
Sort By:
Pageof 30
BMJ Open|October 6, 2019
Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation studyKatsunori Miyake, Motoki Endo, Masayoshi Okumi, et al.Drug Metabolism and Pharmacokinetics|September 23, 2018
Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivoKeisuke Oda, Nobuhiro Mori, Masayoshi Okumi, et al.IJU Case Reports|August 4, 2020
Living-donor kidney transplantation in an end-stage renal disease patient with situs inversus totalis: Three case reportsAtsuhiko Ochi, Kohei Unagami, Takafumi Akanuma, et al.Kidney360|July 9, 2026
Early Post-Transplant Hyperuricemia and Association with Histologic Fibrosis Progression and EMT-Related Changes in Proximal Tubular CellsMayuko Kawabe, Yasuyuki Nakada, Izumi Yamamoto, et al.Scientific Reports|September 9, 2022
Tropomyosin micelles are the major components contributing to the white colour of boiled shellfish soupsTakashi Akihiro, Ryo Yasui, Shinji Yasuhira, et al.Journal of Transplantation|March 10, 2022
Mammalian Target of Rapamycin Inhibitors and Wound Healing Complications in Kidney Transplantation: Old Myths and New RealitiesMuhammad Abdul Mabood Khalil, Saeed M G Al-Ghamdi, Ubaidullah Shaik Dawood, et al.Transplant Immunology|July 14, 2010
Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeysKiyoshi Setoguchi, Hidehiro Kishimoto, Sakiko Kobayashi, et al.Japanese Journal of Clinical Oncology|April 4, 2022
Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-upHiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, et al.International Journal of Clinical Oncology|February 13, 2020
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institutionToshio Takagi, Kazuhiko Yoshida, Arisa Wada, et al.Transplantation|October 27, 2005
Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppressionHiroaki Shimmura, Kazunari Tanabe, Hideki Ishida, et al.Pageof 30